Skip to main content

Positive results for Inovio Pharmaceuticals' flu vaccine

Inovio Pharmaceuticals Inc. (Nasdaq: INO) announced that its synthetic flu vaccine protected multiple animal models from all major deadly strains of H1 influenza viruses from the last 100 year. Shares of the biopharmaceutical leaped $1.05 to close at $5.69.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.